- Home
- OLPX vs TSHA Comparison
OLPX vs TSHA Comparison
Compare OLPX & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLPX
- TSHA
- Stock Information
- Founded
- OLPX 2014
- TSHA 2019
- Country
- OLPX United States
- TSHA United States
- Employees
- OLPX N/A
- TSHA N/A
- Industry
- OLPX Package Goods/Cosmetics
- TSHA Biotechnology: Pharmaceutical Preparations
- Sector
- OLPX Consumer Discretionary
- TSHA Health Care
- Exchange
- OLPX Nasdaq
- TSHA Nasdaq
- Market Cap
- OLPX 844.1M
- TSHA 728.4M
- IPO Year
- OLPX 2021
- TSHA 2020
- Fundamental
- Price
- OLPX $1.47
- TSHA $2.49
- Analyst Decision
- OLPX Hold
- TSHA Strong Buy
- Analyst Count
- OLPX 4
- TSHA 7
- Target Price
- OLPX $1.85
- TSHA $7.57
- AVG Volume (30 Days)
- OLPX 1.1M
- TSHA 4.9M
- Earning Date
- OLPX 08-05-2025
- TSHA 08-11-2025
- Dividend Yield
- OLPX N/A
- TSHA N/A
- EPS Growth
- OLPX N/A
- TSHA N/A
- EPS
- OLPX 0.02
- TSHA N/A
- Revenue
- OLPX $420,742,000.00
- TSHA $7,224,000.00
- Revenue This Year
- OLPX $1.32
- TSHA N/A
- Revenue Next Year
- OLPX $2.25
- TSHA N/A
- P/E Ratio
- OLPX $77.99
- TSHA N/A
- Revenue Growth
- OLPX N/A
- TSHA N/A
- 52 Week Low
- OLPX $1.01
- TSHA $1.05
- 52 Week High
- OLPX $2.77
- TSHA $3.82
- Technical
- Relative Strength Index (RSI)
- OLPX 63.13
- TSHA 43.80
- Support Level
- OLPX $1.25
- TSHA $2.48
- Resistance Level
- OLPX $1.51
- TSHA $2.66
- Average True Range (ATR)
- OLPX 0.08
- TSHA 0.21
- MACD
- OLPX 0.02
- TSHA -0.07
- Stochastic Oscillator
- OLPX 86.54
- TSHA 2.17
About OLPX Olaplex Holdings Inc.
Olaplex Holdings Inc is a science-enabled, technology-driven beauty company. It offers science-backed solutions that improve hair health. It identifies the majority of consumers' relevant haircare concerns in collaboration with the community of professional hairstylists and consumers and strives to address them through its proprietary technology and innovation capabilities. It offers products through an omnichannel platform that serves professional, specialty retail, and DTC channels. The company derives its revenue through the sale of its hair care products. The company generates the majority of revenue from Professional sales channels followed by Specialty Retail and then DTC. Geographically the company generates the majority of its revenue from the International market.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.